At its R&D event held on Dec 12, Ligand Pharmaceuticals LGND provided an overview of its business model and issued fresh guidance outlook for the next five years. Ligand issued fresh guidance for 2024 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback